2-amino-5-phosphonovalerate has been researched along with u 69593 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Chavkin, C; Drake, CT; Milner, TA; Simmons, ML; Terman, GW | 1 |
Fields, HL; Hjelmstad, GO | 1 |
3 other study(ies) available for 2-amino-5-phosphonovalerate and u 69593
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Opioid modulation of recurrent excitation in the hippocampal dentate gyrus.
Topics: 2-Amino-5-phosphonovalerate; Analgesics; Animals; Axons; Benzeneacetamides; Dendrites; Dentate Gyrus; Dynorphins; Guinea Pigs; In Vitro Techniques; Long-Term Potentiation; Male; Nerve Fibers; Neurons; Pyrrolidines; Receptors, GABA-A; Receptors, Opioid, kappa; Synapses | 2000 |
Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzeneacetamides; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Neural Inhibition; Neurons; Nucleus Accumbens; Patch-Clamp Techniques; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Receptors, Opioid, mu; Synaptic Transmission | 2001 |